A New Blood Score for Myelofibrosis Staging

Not yet recruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions

Myeloproliferative Neoplasm

Interventions

DIAGNOSTIC_TEST

Blood sampling

Blood samples will be collected at diagnosis, in the same time as BOM is performed

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06177366 - A New Blood Score for Myelofibrosis Staging | Biotech Hunter | Biotech Hunter